These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2140281)

  • 1. [Chemotherapy of cancer of the exocrine pancreas].
    Bonneterre J
    Bull Cancer; 1990; 77(3):267-74. PubMed ID: 2140281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy for advanced pancreatic carcinoma].
    Yokoyama T; Shimada Y
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2338-43. PubMed ID: 1463339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAM chemotherapy +/- aminoglutethimide in the treatment of pancreatic carcinoma.
    Lipton A; Harvey HA; Santen RJ; Stryker JA; Barnes SG; Walker BK; Dixon RH; Givant EM; Bartholomew MJ; Nadjafi C
    Eur J Surg Oncol; 1990 Feb; 16(1):12-4. PubMed ID: 2307239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group.
    J Natl Cancer Inst; 1988 Jul; 80(10):751-5. PubMed ID: 2898536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prospective randomized trial comparing modified FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus 5-FU alone for the treatment of non-resectable pancreatic and biliary tract carcinomas (the 1st trial in non-resectable patients). Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract].
    Takada T; Kato H; Sasaki M; Matsushiro T; Yamauchi H; Kajihara T; Watanabe G; Hanaue H; Yoshida K; Shimizu T
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1295-301. PubMed ID: 1503483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy of pancreatic cancer].
    Yoshimori M; Tajiri H; Nakamura K; Ozaki H
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):227-34. PubMed ID: 3155930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prospective randomized trial comparing 1/2 FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus palliative therapy for the treatment of unresectable pancreatic and biliary tract carcinomas (the 2nd trial in non-resectable patients). Japanese Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract].
    Takada T; Kato H; Matsushiro T; Nimura Y; Nagakawa T; Nakayama T; Yamauchi H; Ogata Y; Shimada H; Miyakawa S; Yamaguchi A; Sakoda K; Yasuda H; Tsukada K; Yoshida K; Ashida H; Ishikawa Y; Kotoura Y; Kinoshita H; Kajiwara T; Watanabe G; Uchimura M; Funabiki T; Ikeda S; Okada S
    Gan To Kagaku Ryoho; 1996 May; 23(6):707-14. PubMed ID: 8645022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term arterial infusion chemotherapy in unresectable pancreatic cancer].
    Kakizaki K; Yamauchi H; Takahashi N; Kikuti H; Asamura M
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2740-2. PubMed ID: 2506819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot study.
    Theodors A; Bukowski RM; Hewlett JS; Livingston RB; Weick JK
    Am J Clin Oncol; 1982 Oct; 5(5):555-8. PubMed ID: 6217742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C for non-resectable pancreatic and biliary carcinoma: multicenter randomized trial.
    Takada T; Nimura Y; Katoh H; Nagakawa T; Nakayama T; Matsushiro T; Amano H; Wada K
    Hepatogastroenterology; 1998; 45(24):2020-6. PubMed ID: 9951857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
    Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
    Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical Research.
    De Lisi V; Cocconi G; Angelini F; Cavicchi F; Di Costanzo F; Gilli G; Rodinò C; Soldani M; Tonato M; Finardi C
    Cancer; 1996 Jan; 77(2):245-50. PubMed ID: 8625230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperthermia: microwave hyperthermia in combination with intra-arterial infusion chemotherapy of cancer of the pancreas].
    Miura T; Hatta Y; Endo Y; Sassa T; Yoshikawa N; Hirose N; Funatomi H; Taguchi S
    Gan No Rinsho; 1985 May; 31(6 Suppl):704-11. PubMed ID: 2411966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of implantable drug delivery system (Port-A-Cath) in cancer chemotherapy].
    Okawa T; Kita M
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2659-63. PubMed ID: 3415263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intra-arterial infusion chemotherapy in non-resectable pancreatic cancer using angiotensin-II and implantable drug delivery system].
    Maruyama T; Koura Y; Kurisu Y; Kuroi K; Kai Y
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2735-9. PubMed ID: 2551218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomized clinical trial of two drug delivery pathway in the treatment of inoperable advanced pancreatic carcinoma.
    Han GH; Yin ZX; Meng XJ; He CY; Zhang HB; Sun AH; Wu KC; Ding J; Fan DM
    Chin J Dig Dis; 2006; 7(1):45-8. PubMed ID: 16412037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of intra-arterial infusion chemotherapy and radical pancreatectomy in patients with locally advanced pancreatic cancer].
    Ohigashi H; Ishikawa O; Nakamori S; Sasaki Y; Masutani S; Kameyama M; Hiratsuka M; Kabuto T; Furukawa H; Imaoka S
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1672-5. PubMed ID: 8373245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new regional arterial infusion chemotherapy for patients with advanced pancreatic cancer].
    Homma H; Niitsu Y
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):383-9. PubMed ID: 11915727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group.
    J Clin Oncol; 1986 Dec; 4(12):1794-8. PubMed ID: 2946815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.
    Takada T; Amano H; Yasuda H; Nimura Y; Matsushiro T; Kato H; Nagakawa T; Nakayama T;
    Cancer; 2002 Oct; 95(8):1685-95. PubMed ID: 12365016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.